JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

Rohleder, O
Author Rohleder, O Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: ondrej.rohleder@fnbrno.cz
Mudry, P
Author Mudry, P Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: pmudry@fnbrno.cz
Neradil, J
Author Neradil, J Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University, Kotlarska 2, Brno 611 37, Czech Republic. Electronic address: jneradil@sci.muni.cz
Noskova, H
Author Noskova, H Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: hana.noskova@ceitec.muni.cz
Slaby, O
Author Slaby, O Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: ondrej.slaby@ceitec.muni.cz
Sterba, J
Author Sterba, J Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: jsterb@fnbrno.cz

Bone. 2018 Nov ; 116 () : 171. [epub] 20180807

ISSN 1873-2763
Source

Language English Country United States Media print-electronic

Document type Case Reports, Letter

Persistent link https://www.medvik.cz/link/pmid30096467

PubMed 30096467
DOI 10.1016/j.bone.2018.08.003
PII: S8756-3282(18)30304-1
Knihovny.cz E-resources

MeSH
Imatinib Mesylate pharmacology therapeutic use MeSH
Infant MeSH
Bone and Bones drug effects pathology MeSH
Humans MeSH
Mutation genetics MeSH
Myositis Ossificans drug therapy genetics MeSH
Check Tag
Infant MeSH
Humans MeSH
Female MeSH
Publication type
Letter MeSH
Case Reports MeSH
Names of Substances
Imatinib Mesylate MeSH

Central European Institute of Technology Masaryk University Kamenice 753 5 Brno 625 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic; Division of Medical Genetics Department of Biology University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic; Laboratory of Tumor Biology Department of Experimental Biology School of Science Masaryk University Kotlarska 2 Brno 611 37 Czech Republic

Associated Publication

Bone. 2018 Apr;109:276-280. doi: 10.1016/j.bone.2017.07.019. PubMed

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology

Frontiers in oncology. 2019 ; 9 () : 930. [epub] 20190920

Front Oncol
ISSN 2234-943X
Source

Borrow
RIS

Find record

In BMC

Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

Find record

Citation metrics

Archiving options